Fresenius Medical Care AG & Co. KGaA

  • WKN: 578580
  • ISIN: DE0005785802
  • Land: Deutschland

Nachricht vom 23.03.2020 | 17:56

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Share buy-back
23.03.2020 / 17:56
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Share buy-back - 40th Interim Report

In the period from March 16, 2020 until and including March 20, 2020, a total of 449,021 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

 Aggregated volume in Weighted average share number of shares price in EUR

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 344,779 56.40471
17.03.2020 9,953 59.2980
18.03.2020 9,187 58.8520
19.03.2020 3,000 58.3104
20.03.2020 990 57.3667
 

Chi-X Europe

Day of repurchase Aggregated volume in number of sharesAggregated volume in number of sharesAggregated volume in number of shares Weighted average share price in EUR
16.03.2020 57,482 56.57144
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

BATS Europe

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 9,652 56.4773
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

Turquoise

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 13,978 56.3285
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 20, 2020 therefore amounts to 5,903,049 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., March 23, 2020



23.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Northern Data: "Waren zum richtigen Zeitpunkt mit dem richtigen Konzept am Markt"

Kryptowährungen, allen voran Bitcoin, sind zuletzt mit deutlichen Steigerungen wieder in den Investorenfokus gerückt. Northern Data, ein Spezialist für High Performance Computing, zählt laut eigenen Angaben zu den weltweit führenden Anbietern für Infrastruktur im Bereich Bitcoin-Mining. Wir haben mit dem Gründer und CEO Aroosh Thillainathan über die Perspektiven für Bitcoin und die Wachstumsaussichten für die Northern Data gesprochen.

News im Fokus

Linde Signs Long-Term Agreement with BorsodChem, member of Wanhua Chemical Group

20. Januar 2021, 12:00

Aktuelle Research-Studie

UniDevice AG

Original-Research: UniDevice AG (von GBC AG): Kaufen

20. Januar 2021